Probiotics is named as a drug or biological intervention in 3 clinical trials in our China trial register, 2 of which are recruiting. Lead sponsors include Zhujiang Hospital (1), Gang Xu (1) and Chujin Cao (1). Registered phases: Phase 4 and Phase 2. Conditions studied include NSCLC Diagnosed by Histology or Cytology; A Multidisciplinary Team Assessment Determined That the Patient Was a Suitable Candidate for Radical Surgical Resection; Overall Lung Function is Adequate for the Planned Lung Resection.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07182942 | The Effect and Mechanism of Xiqing Regulating Intestinal Homeostasis on Drug Efficacy of Chronic Kidney Disease (ClinicalTrials.gov ↗) CKD, Drug Effect |
Phase 4 | Recruiting |
| NCT07534033 | Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer (ClinicalTrials.gov ↗) NSCLC Diagnosed by Histology or Cytology, A Multidisciplinary Team Assessment Determined That the Patient Was a Suitable Candidate for Radical Surgical Resection, Overall Lung Function is Adequate for the Planned Lung Resection |
Phase 2 | Recruiting |
| NCT06528015 | Efficacy and Safety of Probiotics Combined With Enteric-coated Budesonide Capsules in Patients With Primary IgA Nephropathy (ClinicalTrials.gov ↗) Glomerulonephritis, IGA, Probiotics, Budesonide |
Phase 4 | Not yet open |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| NSCLC Diagnosed by Histology or Cytology | 1 |
| A Multidisciplinary Team Assessment Determined That the Patient Was a Suitable Candidate for Radical Surgical Resection | 1 |
| Overall Lung Function is Adequate for the Planned Lung Resection | 1 |
| AJCC is Classified as IB-IIIC | 1 |
| Glomerulonephritis, IGA | 1 |
| Probiotics | 1 |
| Budesonide | 1 |
| CKD | 1 |
| Drug Effect | 1 |
| Lead sponsor | Trials |
|---|---|
| Zhujiang Hospital | 1 |
| Gang Xu | 1 |
| Chujin Cao | 1 |
| Register | Probiotics trials |
|---|---|
| Clinical trials in China | 3 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Probiotics works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Probiotics (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 25 Sep 2026.